EMEA

14.05.2025 • Topics • Pharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

13.12.2022 • News

Catalent Opens Cell Therapy Facility in Belgium

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.

23.07.2018 • News

UK Votes to Remain Part of EMA

02.04.2018 • Topics • Chemistry

Helping Customers Meet Market Requirements

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Strategic Response to a Shifting Pharma Landscape

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.